Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Membership
- HDA History
- Member Directory
- Staff Directory
- Industry Recognition
- Executive Committee
- Mission
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- COVID-19 Response
- Pharmacy Services Administrative Organizations
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Product Availability
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Advocacy
- Healthcare Affordability
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Conference and Expo
- PCSC Educational Seminar
- Business and Leadership Conference
- Webinars
- Annual Board and Membership Meeting
- Speaker Resource Center
- Traceability Seminar
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- COVID-19 Response
- Health Delivered
- Professional Development
- Webinars
- PCSC
- Allied Against Opioid Abuse
- Annual Report
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

Health Delivered

HDA distributors move billions of vaccines and supplies every year — from the biggest cities to the smallest towns.

Supply Chain Entering Critical DSCSA Phase

The HDA Research Foundation’s sixth Serialization Readiness Survey indicates trading partners appear to be deferring their DSCSA-related investments.

Download the Survey

Rising to the Challenge of COVID-19

From the early surges of COVID-19 to vaccine distribution, distributors are bringing forward lessons learned of the pandemic response.

Learn More

2022 Distribution Management Conference and Expo

Our annual educational event will take place in Austin, Texas on March 6–9.

FEATURED UPCOMING EVENTS

2022 Distribution Management Conference and Expo

March 6 to 9, 2022 | JW Marriott Austin, Texas

The Distribution Management Conference (DMC) and Expo is HDA's largest supply chain education event, attended by more than 500 manufacturers, distributors, consultants and third parties who keep the pharmaceutical...

View All Events

MEMBER SPOTLIGHT

Anda, Inc. is now part of Teva Pharmaceuticals, a leader in global generics, committed to transforming global healthcare.

Learn More

IN THE NEWS

November 17, 2021

Sean Spears of Eisai Honored With 2021 Nexus Award for Lifetime Achievement

November 12, 2021

HDA Statement on FDA Commissioner Nominee Dr. Robert Califf

November 1, 2021

HDA Foundation Survey Reveals Uneven Progress on Rx Product Serialization, with 2023 DSCSA Requirements Around the Corner

View All News

ISSUES IN DISTRIBUTION

Pharmaceutical Traceability

HDA is now leading industry efforts to implement the 2013 Drug Supply Chain Security Act (DSCSA) that replaced a 50-state patchwork of pedigree requirements with one federal solution to trace prescription...

Healthcare Affordability

With HDA distributors providing between $33–$53 billion in cost savings to the U.S. healthcare economy each year, our industry is committed to improving access to lower-cost, high-quality medicines for...

Prescription Drug Abuse and Diversion

HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious...

Importation of Prescription Medicines

HDA opposes permitting the importation into the U.S. of pharmaceuticals sold or designated for sale in foreign countries. HDA firmly believes that allowing importation increases the likelihood of counterfeit...